Corbus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-10.382; its P/E ratio is -3.63; Corbus Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-1.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -7.31M	$ -9.27M	$ -7.96M	$ -18.62M	$ -11.06M
EBITDA	$ -6.97M	$ -8.92M	-	$ -18.44M	$ -10.59M
Net Income Common Stockholders	$ -8.02M	$ -10.04M	$ -8.78M	$ -17.69M	$ -10.80M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 20.91M	$ 28.73M	$ 36.76M	$ 44.42M	$ 59.39M
Total Assets	$ 28.27M	$ 36.28M	$ 43.72M	$ 51.65M	$ 66.31M
Total Debt	$ 20.88M	$ 22.86M	$ 23.72M	$ 24.84M	$ 25.09M
Net Debt	$ -21.77K	$ -5.88M	$ -13.04M	$ -19.58M	$ -34.30M
Total Liabilities	$ 35.18M	$ 35.97M	$ 34.20M	$ 35.19M	$ 33.32M
Stockholders Equity	$ -6.90M	$ 311.02K	$ 9.52M	$ 16.46M	$ 32.99M
Cash Flow	-
Free Cash Flow	$ -6.01M	$ -7.18M	-	$ -15.11M	$ -7.45M
Operating Cash Flow	$ -6.01M	$ -7.18M	-	$ -15.11M	$ -7.45M
Investing Cash Flow	$ 10.39M	$ 10.90M	-	$ 5.55M	$ 11.78M
Financing Cash Flow	$ -1.90M	$ -820.50K	-	$ -113.01K	$ 234.32K

Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

Income Statement >

Corbus Pharmaceuticals Debt to Assets

Balance Sheet >

Corbus Pharmaceuticals Cash Flow

Cash Flow >

Corbus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing